SEC 13F Intelligence

D. E. Shaw & Co., Inc. / PFE

D. E. Shaw & Co., Inc.’s Pfizer Inc Position

Does D. E. Shaw & Co., Inc. own Pfizer Inc (PFE)? Yes — 12.47M shares worth $350M (+0.21% of its 13F portfolio) as of Q1 2026, up from 3.42M shares the prior filed quarter.

Position Value
$350M
Q1 2026
Shares
12.47M
% of Portfolio
+0.21%
Quarters Held
30
currently held

Position History PFE

Reported value by quarter
Q4 ’18: $23MQ4 ’18Q1 ’19: $461MQ2 ’19: $154MQ3 ’19: $118MQ4 ’19: $134MQ4 ’19Q1 ’20: $383MQ2 ’20: $319MQ3 ’20: $222MQ4 ’20: $64MQ4 ’20Q1 ’21: $53MQ2 ’21: $236MQ3 ’21: $193MQ4 ’21: $196MQ4 ’21Q1 ’22: $510MQ2 ’22: $151MQ3 ’22: $125MQ4 ’22: $372MQ4 ’22Q1 ’23: $311MQ2 ’23: $238MQ3 ’23: $436MQ4 ’23: $418MQ4 ’23Q1 ’24: $674MQ2 ’24: $236MQ3 ’24: $160MQ4 ’24: $204MQ4 ’24Q1 ’25: $152MQ2 ’25: $91MQ3 ’25: $150MQ4 ’25: $85MQ4 ’25Q1 ’26: $350Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202612.47M$350M+0.21%
Q4 20253.42M$85M+0.05%
Q3 20255.90M$150M+0.08%
Q2 20253.75M$91M+0.06%
Q1 20255.99M$152M+0.14%
Q4 20247.71M$204M+0.15%
Q3 20245.52M$160M+0.14%
Q2 20248.42M$236M+0.22%
Q1 202424.29M$674M+0.58%
Q4 202314.52M$418M+0.37%
Q3 202313.15M$436M+0.46%
Q2 20236.48M$238M+0.24%
Q1 20237.62M$311M+0.33%
Q4 20227.26M$372M+0.41%
Q3 20222.85M$125M+0.15%
Q2 20222.88M$151M+0.18%
Q1 20229.86M$510M+0.48%
Q4 20213.32M$196M+0.16%
Q3 20214.48M$193M+0.17%
Q2 20216.02M$236M+0.20%
Q1 20211.45M$53M+0.05%
Q4 20201.75M$64M+0.06%
Q3 20206.06M$222M+0.23%
Q2 20209.75M$319M+0.38%
Q1 202011.75M$383M+0.60%
Q4 20193.41M$134M+0.15%
Q3 20193.27M$118M+0.14%
Q2 20193.55M$154M+0.19%
Q1 201910.85M$461M+0.60%
Q4 2018523.7K$23M+0.03%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See D. E. Shaw & Co., Inc.’s full portfolio or all institutional holders of PFE.